Rani Therapeutics

Rani Therapeutics is a clinical-stage biotherapeutics company focused on developing oral delivery methods for biologics and drugs. Their proprietary technology, the RaniPill capsule, is a robotic pill designed to deliver medication directly into the small intestine, bypassing the stomach's acidic environment where drugs are typically broken down. Rani has successfully conducted preclinical and clinical studies to evaluate the safety, tolerability, and bioavailability of the RaniPill capsule.

Rani's mission is to improve the lives of millions of patients by replacing painful and inconvenient injections with a convenient and effective oral option. They have a robust pipeline of drug candidates, including oral versions of ustekinumab, octreotide, PTH, TNF-alpha inhibitors, and human growth hormone. They are dedicated to transforming medicine and improving patient outcomes by making oral biologics a reality.

Rani Therapeutics is a clinical-stage biotherapeutics company committed to revolutionizing medicine by developing a novel platform technology that enables the oral delivery of biologic drugs. Their mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful and inconvenient injections with a painless, easy-to-swallow pill, the RaniPill capsule. The RaniPill capsule is designed to protect biologics from degradation in the stomach and deliver them directly to the small intestine for optimal absorption.

Rani Therapeutics fosters a culture of innovation and collaboration, driven by a shared passion for improving patient lives. The company values a diverse range of expertise, bringing together individuals with backgrounds in science, engineering, medicine, and other fields to work towards their mission of revolutionizing drug delivery. This collaborative environment encourages open communication and a willingness to take risks, reflecting their commitment to developing groundbreaking solutions in the healthcare industry.

Rani Therapeutics, a clinical-stage biotherapeutics company, is committed to fostering a diverse, equitable, and inclusive workplace that values the contributions of all employees. They believe that a diverse workforce with a variety of perspectives and backgrounds strengthens their ability to innovate and deliver high-quality treatments to patients. The company strives to create an environment where everyone feels respected, valued, and empowered to succeed.